YC’s Latest Batch Reveals a Massive Pivot Toward Physical Robotics and Biotech
AI Summary
While software-as-a-service declines, venture capital is flooding into startups building physical robots, autonomous systems, and drug discovery tools.
The latest Y Combinator Demo Day showcased a dramatic shift in startup trends. Out of the hundreds of presenting startups, a record 35% focused on “hard tech,” including humanoid robot components, custom hardware chips, and computational biology.
Investors note that standard SaaS models are facing saturation, while AI breakthroughs have made physical robotics and drug discovery cheaper and faster to prototype than ever before.